Companies ›Financials ›CNO

CNO — NYSE Life & Health Insurance

CNO Financial Group, Inc.

$55,26

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

5,3B USD

P/E

22,5x

EV / Rev

—

Div yield

1,25 %

Op margin

12,3 %

ROE

9,2 %

Net margin

5,1 %

Debt / equity

—

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

$53,49

Open

—

Next earnings

2026-10-28

Ex-dividend

—

TR 1Y

—

About

CNO Financial Group, Inc. operates as a multiline insurance and broker provider, generating revenue through life insurance, annuities, and health products within the Financials sector.

Business. CNO Financial Group, Inc. (NYSE: CNO) is a financial services company operating in the Life & Health Insurance industry. The firm primarily engages in the sale of life and health insurance products. Specific details regarding its operating segments and geographic presence are not provided in the available data. The company is headquartered in the United States and is listed on the New York Stock Exchange.

Classification99 %

SectorFinancials

Industry groupLife & Health Insurance

Generated · model-assisted

Sell-side consensus

HOLD6 analysts

0 buy5 hold1 sell

Avg 12m price target55,66

Analyst recommendations

6 analysts · consensus Hold

Buy0

Hold5

Sell1

12-month price target

55,66

Consensus of sell-side coverage.

Upcoming events

EarningsQ3 2026 earnings (expected)2026-10-28 · estimated

See all catalysts →

At a glance

Score

—

not yet scored

6 analysts · indicative

Ownership→

American Century Investment Management, Inc.

largest disclosed fund holder

Profitability→

9,2 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning CNO.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to CNO. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Company
EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR
Congressional trades
CongressLisa McClain — CNO Financial Group, Inc. Common2025-06-11 · Republican · MI · Sale · $1,001 - $15,000
CongressLisa McClain — CNO Financial Group, Inc. Common2025-06-09 · Republican · MI · Purchase · $1,001 - $15,000

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

CNO Financial Group, Inc. (NYSE: CNO) is a financial services company operating in the Life & Health Insurance industry. The firm primarily engages in the sale of life and health insurance products. Specific details regarding its operating segments and geographic presence are not provided in the available data. The company is headquartered in the United States and is listed on the New York Stock Exchange.

Classification99 %

SectorFinancials

Industry groupLife & Health Insurance

AI synthesis

GENERATED

CNO Financial Group maintains a capital structure characterized by zero reported debt-to-equity, resulting in a leverage-free balance sheet profile. Total assets stand at $38.96 billion against total liabilities of $36.47 billion, yielding total equity of $2.50 billion. The company holds a current ratio that is not explicitly quantified in the snapshot but operates with $148.8 million in operating cash flow for the period. Liquidity risk is flagged as unknown due to insufficient balance-sheet inputs for precise assessment, though the absence of debt suggests low immediate solvency pressure.

Profitability metrics indicate a return on equity of 9.18% and a return on assets of 0.59% for the latest period. The price-to-earnings ratio is 22.47, while the price-to-book and price-to-tangible-book ratios both stand at 2.12. Operating income reached $129.9 million on revenue of $1.03 billion, resulting in net income of $37.7 million. These returns are evaluated against cohort medians which are not provided in the input data, preventing direct comparative analysis of margin efficiency or capital productivity relative to peers.

Key takeaways

Zero debt-to-equity ratio provides a strong balance sheet foundation but may indicate under-leveraged capital efficiency.
Medium dilution risk is flagged due to potential offering activities or equity-based compensation structures.
Recent $5.2 million impairment charge reflects strategic exit from the Worksite fee services business.
Analyst consensus is neutral with a median price target near the current trading price, suggesting limited near-term upside expectations.
Significant exposure to interest rate risk and regulatory changes in health insurance pricing and dividend approvals.

Bull / Bear case

Generated · model-assisted

BULL CASE · 2

CNO Financial Group generated $4.49 billion in FY2024 revenue, demonstrating substantial top-line scale within the life and health insurance sector.

Net margin of 5.11% in FY2025 exceeded the cohort median, suggesting effective cost management despite fluctuating net income levels.

BEAR CASE · 4

Revenue declined 12.8% year-over-year in FY2025, indicating a contraction in top-line growth and potential market share loss.

The company carries a high leverage band with a debt-to-equity ratio of 13.70, increasing financial risk and sensitivity to interest rates.

Interest coverage ratio of 2.40 suggests limited buffer for debt servicing, exposing the firm to potential liquidity constraints during downturns.

Medium dilution risk flags potential equity value erosion, threatening existing shareholder ownership percentages and per-share earnings metrics.

In focus — financials by report

Quarterly

Annual

QUARTERLYFiled 2026-03-31

Q4 2025 · Quarter highlights

Revenue $1.03B; Operating income $129.9M.

Revenue$1.03B

Operating income$129.9M

Net income$37.7M

Free cash flow—

EPS—

Operating cash flow$148.8M

Financials

Income statement

Revenue$1.03B

Gross profit—

Operating income$129.9M

Net income$37.7M

Margins

Gross margin—

Operating margin12.6%

Net margin3.7%

FCF margin—

Balance sheet

Total assets$38.96B

Total liabilities$36.47B

Total equity$2.50B

Cash & equivalents—

Long-term debt—

Cash flow

Operating cash flow$148.8M

CapEx—

Free cash flow—

SBC—

P&L flow · revenue → net income

Highlights

▍Revenue $1.03B
▍Operating income $129.9M
▍Net margin 3.7%

Valuation FY

Market price

$55,26

Market cap

$5.15B

Enterprise valueⓘ

—

P/Eⓘ

22.5x

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

2.1x

P / Tangible bookⓘ

2.1x

Tangible book

$2.43B

Net cashⓘ

—

Current ratioⓘ

—

Debt / equityⓘ

—

ROAⓘ

0.6%

ROEⓘ

9.2%

Cash conversionⓘ

295.0%

CapEx / revenueⓘ

—

SBC / revenueⓘ

—

Dilution ratioⓘ

2.5%

Revenue by segment

Business relationships

Business relationships31 disclosed relationships · 1 type · extracted from filings & disclosures

Subsidiaries31

EX21:167107e7cad8EX21:167107e7cad8Subsidiarie97%

EX21:17b70ed18c57EX21:17b70ed18c57Subsidiarie97%

EX21:182001143818EX21:182001143818Subsidiarie97%

EX21:1f9f1a9aab03EX21:1f9f1a9aab03Subsidiarie97%

EX21:2194cbb879edEX21:2194cbb879edSubsidiarie97%

EX21:258f243e09d5EX21:258f243e09d5Subsidiarie97%

EX21:2d5ee74c13c9EX21:2d5ee74c13c9Subsidiarie97%

EX21:3278ab0b2a63EX21:3278ab0b2a63Subsidiarie97%

EX21:32cdb8223d2cEX21:32cdb8223d2cSubsidiarie97%

EX21:3692fadf7824EX21:3692fadf7824Subsidiarie97%

EX21:390f474ec80eEX21:390f474ec80eSubsidiarie97%

EX21:424d4521a50dEX21:424d4521a50dSubsidiarie97%

EX21:471a317a5ac7EX21:471a317a5ac7Subsidiarie97%

EX21:51388ea013a6EX21:51388ea013a6Subsidiarie97%

EX21:55ab98f9f192EX21:55ab98f9f192Subsidiarie97%

EX21:5b1264444acdEX21:5b1264444acdSubsidiarie97%

EX21:6946dc59f3caEX21:6946dc59f3caSubsidiarie97%

EX21:69feb4e25a5cEX21:69feb4e25a5cSubsidiarie97%

EX21:7b52b5548eabEX21:7b52b5548eabSubsidiarie97%

EX21:7f4c73c4ca88EX21:7f4c73c4ca88Subsidiarie97%

EX21:86cdb45296c1EX21:86cdb45296c1Subsidiarie97%

EX21:93406ec00757EX21:93406ec00757Subsidiarie97%

EX21:9e5425cc99d1EX21:9e5425cc99d1Subsidiarie97%

EX21:a0580121a867EX21:a0580121a867Subsidiarie97%

EX21:cd1a357fcc13EX21:cd1a357fcc13Subsidiarie97%

EX21:daec2f53cb7bEX21:daec2f53cb7bSubsidiarie97%

EX21:e6600b19766bEX21:e6600b19766bSubsidiarie97%

EX21:e83525aa17bcEX21:e83525aa17bcSubsidiarie97%

EX21:ee36b5d62192EX21:ee36b5d62192Subsidiarie97%

EX21:f712f74d90b9EX21:f712f74d90b9Subsidiarie97%

EX21:f7ee470be767EX21:f7ee470be767Subsidiarie97%

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Consensus distribution

sell-side coverage

Recommendation distribution6 analysts

Strong buy1

Buy0

Hold4

Sell1

Strong sell0

12-month price target$46,00 · Median $45,00

Low $43,00High $51,00

EPS surprise

+0,2 %

reported vs consensus · beat

Revenue surprise

+10,8 %

reported vs consensus · beat

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

Low$47,00

Mean$55,66

Median$53,00

High$71,30

Spot$55,26

+0.7 %implied to mean12-month sell-side price targets · ▲ spot

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskMedium

Liquidity riskUnknown

Filing-based flags

Source documents mention dilution or offering risk.

Benchmarks vs cohort

Op Margin12,3 %Above median

Net Margin5,1 %Above median

ROE9,2 %Above median

D/E0,00Above median

Cash Conv2,95Above median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

Derivative transactions

Net disposed 83 180 sh4 exercises3 insiders

Bhojwani Gary C.Director, Chief Executive Officer · Employee Stock Option (Right to Buy) → Common StockDisposed 44 250 @ $21,06exercise · 2026-06-30
Tarasi Rocco F. IIIChief Marketing Officer · Employee Stock Option (Right to Buy) → Common StockDisposed 5 750 @ $21,06exercise · 2026-06-11
Goldberg Scott L.President, Consumer Division · Employee Stock Option (Right to Buy) → Common StockDisposed 11 060 @ $21,06exercise · 2026-03-20
Goldberg Scott L.President, Consumer Division · Employee Stock Option (Right to Buy) → Common StockDisposed 22 120 @ $21,06exercise · 2026-03-19

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Regulatory filings
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data
Reference data

How metrics are computed

Cash Conversion Ratio
operating_cash_flow / net_income
Market Price
input from market-data provider (delayed close or quote-shim mid)
Return On Equity
net_income / total_equity
Market Cap
market_price * shares_outstanding_diluted
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic

Source documents

CNO Financial Group, Inc. company facts · 2026-08-01
CNO Financial Group, Inc. 10-Q 2026-05-07 · 2026-08-01
CNO Financial Group, Inc. 10-K 2026-02-24 · 2026-08-01
CNO Financial Group, Inc. 10-Q 2025-11-06 · 2026-08-01
CNO Financial Group, Inc. 10-Q 2025-08-06 · 2026-08-01
8-K (sec_8k_material) on CNO · 2026-08-01
CNO Financial Group Inc Market data — analyst estimates · 2026-08-01
CNO Financial Group Inc Market data — ESG · 2026-08-01

Ownership & reference

Top holders

American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,08 %$147M
Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,04 %$161M
Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,03 %$61M
Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,03 %$139M
AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,03 %$62M
Victory Capital Management Inc.Investment Managers · as of 2026-03-310,02 %$24M
BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,01 %$406M
Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,01 %$61M
Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,01 %$495M
Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,01 %$37M
Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,01 %$44M
Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,01 %$50M
Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,01 %$103M
Nuveen LLCInvestment Managers · as of 2024-12-310,01 %$22M
State Street Investment Management (US)Investment Managers · as of 2026-03-310,01 %$165M
AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$19M
Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$71M
Invesco QQQ TrustFunds · as of 2026-03-310,00 %$20M
AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$8M
FMR LLCInstitutional Investor · as of 2026-03-310,00 %$40M
First Trust Advisors L.P.Investment Managers · as of 2026-03-310,00 %$3M
JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$2M
Jennison Associates LLCInvestment Managers · as of 2026-03-310,00 %$1M
UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$3M
Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$2M
T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$2M
Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$2M
PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

Insider activity

Net selling0 buys · 8 sellsnet -$6,1M20 insiders · last 365d

Tarasi Rocco F. IIIChief Marketing Officer · Common StockSold 1 891 @ $51,31$97K · 2026-07-01
Bhojwani Gary C.Director, Chief Executive Officer · Common StockOther 44 250 @ $21,06$932K · 2026-06-30
Bhojwani Gary C.Director, Chief Executive Officer · Common StockSold 41 798 @ $51,48$2,2M · 2026-06-30
Bhojwani Gary C.Director, Chief Executive Officer · Common StockSold 44 250 @ $51,48$2,3M · 2026-06-30
Tarasi Rocco F. IIIChief Marketing Officer · Common StockOther 5 750 @ $21,06$121K · 2026-06-11
Tarasi Rocco F. IIIChief Marketing Officer · Common StockSold 5 750 @ $50,00$288K · 2026-06-11
Tarasi Rocco F. IIIChief Marketing Officer · Common StockSold 3 308 @ $49,00$162K · 2026-06-10
Goldberg Scott L.President, Consumer Division · Common StockOther 396 @ $47,12$19K · 2026-06-04
Tarasi Rocco F. IIIChief Marketing Officer · Common StockSold 4 808 @ $47,00$226K · 2026-06-02
Brown Archie MDirector · Common StockOther 3 574 @ $46,17$165K · 2026-05-12
Lee AdrianneDirector · Common StockOther 3 574 @ $46,17$165K · 2026-05-12
Foss David BDirector · Common StockOther 3 574 @ $46,17$165K · 2026-05-12
Maurer Daniel RDirector · Common StockOther 6 043 @ $46,17$279K · 2026-05-12
Ragavan Chetlur SDirector · Common StockOther 3 574 @ $46,17$165K · 2026-05-12
Shebik Steven EDirector · Common StockOther 3 574 @ $46,17$165K · 2026-05-12
Turner Jessica ADirector · Common StockOther 3 574 @ $46,17$165K · 2026-05-12
Gibson Linda T.Director · Common StockOther 3 574 @ $46,17$165K · 2026-05-12
DeToro Karen J.President, Worksite Division · Common StockOther 4 400 · 2026-05-11
McDonough Paul H.Chief Financial Officer · Common StockOther 13 063 @ $40,61$530K · 2026-03-25
Koehneman Joel T.Chief Accounting Officer · Common StockOther 202 @ $40,61$8K · 2026-03-25
Zimpfer Matthew J.General Counsel · Common StockOther 7 481 @ $40,61$304K · 2026-03-25
Williams Jeremy D.Chief Actuary · Common StockOther 1 005 @ $40,61$41K · 2026-03-25
Tarasi Rocco F. IIIChief Marketing Officer · Common StockOther 4 141 @ $40,61$168K · 2026-03-25
Mead Michael E.Chief Information Officer · Common StockOther 1 953 @ $40,61$79K · 2026-03-25
Linnenbringer Jeanne L.Chief Operations Officer · Common StockOther 1 649 @ $40,61$67K · 2026-03-25

Short positioning

1.7Mshares short-27.4% vs prior

2.16days to cover

56.7%short of daily vol

40fails-to-deliver

as of 2026-07-15 · short-interest report (free)

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

CNOCanonical

NYSE · USD

Intel & risk

What changed

no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)

Narrative— → —medium
Business summary— → —medium
Conclusion— → —medium
Key takeaways— → —medium
Company share pct— → —medium

vs prior analysis today

peak dispatch · —

OSINT findings

Dilution riskMedium

Liquidity riskUnknown

Source documents mention dilution or offering risk.

Relationship graph

This companySectorSubsidiaries

Evidence & claims

From filings & derived data

EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -40.7%Derived (calculated)
Revenue (YoY) (2025-12-31 vs 2024-12-31): 0.9%Derived (calculated)
EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -40.9%Derived (calculated)
Net income (YoY) (2025-12-31 vs 2024-12-31): -45.5%Derived (calculated)
Return on assets (FY 2025-12-31): 0.6%Derived (calculated)
Return on equity (FY 2025-12-31): 8.7%Derived (calculated)
Net margin (FY 2025-12-31): 5.1%Derived (calculated)
Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 7.6%Derived (calculated)
Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 2.3%Derived (calculated)
Total assets (YoY) (2025-12-31 vs 2024-12-31): 2.5%Derived (calculated)
Operating income (YoY) (2025-12-31 vs 2024-12-31): 0.4%Derived (calculated)
Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 4.9%Derived (calculated)
Debt-to-equity (FY 2025-12-31): 13.70xDerived (calculated)
Shareholders' equity (annual): USD 2.64BSEC XBRL filing
Net income (annual): USD 229.3MSEC XBRL filing
Revenue (annual): USD 4.49BSEC XBRL filing
Pre-tax income (annual): USD 293.4MSEC XBRL filing
Shares outstanding (annual): 94.48MSEC XBRL filing
Total assets (annual): USD 38.79BSEC XBRL filing
Operating income (annual): USD 553.2MSEC XBRL filing
EPS (diluted) (annual): USD-PER-SHARES 2SEC XBRL filing
Interest expense (annual): USD 230.9MSEC XBRL filing
EPS (basic) (annual): USD-PER-SHARES 2SEC XBRL filing
Total liabilities (annual): USD 36.15BSEC XBRL filing

Showing 24 of 60 surfaced claims.

Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

The Thread

Everything we know, in order

2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date

2026-07-31EVENTQ2 2026 earnings (confirmed · filed)

2026-07-30 00:00 UTCTRANSCRIPTEarnings call — Q3 2026

2026-07-01INSIDERTarasi Rocco F. III sold 1.9k sh Common Stock — Chief Marketing Officer ~$97k

2026-06-30INSIDERBhojwani Gary C. sold 44.2k sh Common Stock — Director, Chief Executive Officer ~$2.28M

2026-06-30INSIDERBhojwani Gary C. sold 41.8k sh Common Stock — Director, Chief Executive Officer ~$2.15M

2026-06-30INSIDERBhojwani Gary C. transacted 44.2k sh Common Stock — Director, Chief Executive Officer ~$932k

2026-06-30INSIDERBhojwani Gary C. disposed of 44.2k sh Employee Stock Option (Right to Buy) — Director, Chief Executive Officer

2026-06-11 00:00 UTCINSIDER6 insider transactions — 2026-06 · net sell $573k 1 derivative

2026-06-11INSIDERTarasi Rocco F. III transacted 5.8k sh Common Stock — Chief Marketing Officer ~$121k

2026-06-11INSIDERTarasi Rocco F. III sold 5.8k sh Common Stock — Chief Marketing Officer ~$288k

2026-06-11INSIDERTarasi Rocco F. III disposed of 5.8k sh Employee Stock Option (Right to Buy) — Chief Marketing Officer

2026-06-10INSIDERTarasi Rocco F. III sold 3.3k sh Common Stock — Chief Marketing Officer ~$162k

2026-06-04INSIDERGoldberg Scott L. transacted 396 sh Common Stock — President, Consumer Division ~$19k

2026-06-02INSIDERTarasi Rocco F. III sold 4.8k sh Common Stock — Chief Marketing Officer ~$226k

2026-05-13FILING8-K filing →

2026-05-12 00:00 UTCINSIDER9 insider transactions — 2026-05 · net buy $1.4M

2026-05-12INSIDERBrown Archie M transacted 3.6k sh Common Stock — Director ~$165k

2026-05-12INSIDERLee Adrianne transacted 3.6k sh Common Stock — Director ~$165k

2026-05-12INSIDERFoss David B transacted 3.6k sh Common Stock — Director ~$165k

2026-05-12INSIDERMaurer Daniel R transacted 6.0k sh Common Stock — Director ~$279k

2026-05-12INSIDERRagavan Chetlur S transacted 3.6k sh Common Stock — Director ~$165k

2026-05-12INSIDERShebik Steven E transacted 3.6k sh Common Stock — Director ~$165k

2026-05-12INSIDERTurner Jessica A transacted 3.6k sh Common Stock — Director ~$165k

2026-05-12INSIDERGibson Linda T. transacted 3.6k sh Common Stock — Director ~$165k

2026-05-11INSIDERDeToro Karen J. transacted 4.4k sh Common Stock — President, Worksite Division

2026-05-07FILING10-Q filing →

2026-04-30FILING8-K filing →

2026-03-31EARNINGSQuarterly results — Q4 2025 Revenue USD 1.03B · Net USD 37.7M

2026-03-26FILINGDEF 14A filing →

2026-03-25 00:00 UTCINSIDER18 insider transactions — 2026-03 · net sell $4.5M 2 derivative

2026-03-25INSIDERMcDonough Paul H. transacted 13.1k sh Common Stock — Chief Financial Officer ~$530k

2026-03-25INSIDERKoehneman Joel T. transacted 202 sh Common Stock — Chief Accounting Officer ~$8k

2026-03-25INSIDERZimpfer Matthew J. transacted 7.5k sh Common Stock — General Counsel ~$304k

2026-03-25INSIDERWilliams Jeremy D. transacted 1.0k sh Common Stock — Chief Actuary ~$41k

2026-03-25INSIDERTarasi Rocco F. III transacted 4.1k sh Common Stock — Chief Marketing Officer ~$168k

2026-03-25INSIDERMead Michael E. transacted 2.0k sh Common Stock — Chief Information Officer ~$79k

2026-03-25INSIDERLinnenbringer Jeanne L. transacted 1.6k sh Common Stock — Chief Operations Officer ~$67k

2026-03-20INSIDERGoldberg Scott L. disposed of 11.1k sh Employee Stock Option (Right to Buy) — President, Consumer Division

2026-03-19INSIDERGoldberg Scott L. disposed of 11.1k sh Employee Stock Option (Right to Buy) — President, Consumer Division

Showing the 40 most recent of 55 entries.

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage

Analyst recommendations

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation FY

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Consensus distribution

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Derivative transactions

Actions

Ask Handelsavisen

Ownership & reference

Top holders

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread